secondari
bacteri
infect
streptococcu
pneumonia
major
caus
morbid
mortal
pandem
pneumococcu
commonli
colon
upper
respiratori
tract
urt
healthi
individu
viral
infect
transform
normal
harmless
commens
organ
potenti
fatal
pathogen
increas
pneumococc
carriag
host
diseas
current
threat
influenza
pandem
increas
antibiot
resist
burden
coinfect
young
age
popul
make
critic
understand
viral
infect
increas
suscept
pneumococc
diseas
pneumococc
colon
mucos
surfac
prerequisit
invas
children
radiolog
confirm
pneumonia
mark
increas
densiti
colon
pneumococci
coinfect
influenza
respiratori
syncyti
viru
sever
possibl
mechan
may
account
increas
nasopharyng
pneumococc
densiti
includ
influenzainduc
damag
epithelium
andor
alter
host
cellular
respons
bacteri
viral
infect
reduc
mucociliari
veloc
denud
epitheli
surfac
expos
basement
membran
modul
chemokin
innat
use
experiment
human
pneumococc
carriag
ehpc
investig
relationship
asymptomat
urt
viral
infect
pneumococc
colon
human
experiment
carriag
offer
uniqu
opportun
investig
mucos
set
onset
termin
well
densiti
pneumococc
carriag
episod
studi
hypothes
subject
asymptomat
urt
viral
infect
would
suscept
pneumococc
carriag
acquisit
andor
would
increas
carriag
densiti
observ
viru
associ
increas
odd
becom
colon
experiment
inocul
investig
possibl
mechan
viru
could
modul
mucos
defens
increas
colon
measur
level
sever
solubl
innat
factor
nasal
mucosa
observ
level
human
factor
h
fh
increas
subject
coinfect
viru
pneumococcu
fh
solubl
protein
found
human
plasma
suppress
altern
complement
well
describ
pneumococcu
bind
fh
via
pneumococc
surfac
protein
c
pspc
facilit
adher
epitheli
pspc
also
interact
human
polymer
immunoglobulin
ig
receptor
promot
bacteri
adher
invas
epitheli
cell
well
bind
secretori
compon
immunoglobulin
iga
result
import
interact
host
immun
system
pspc
propos
vaccin
candid
block
pneumococc
process
fhmediat
adher
uptak
pneumococci
describ
first
initi
contact
fhcoat
pneumococci
mediat
glycosaminoglycan
express
surfac
human
cell
second
step
pneumococc
uptak
integrin
mediat
depend
host
signal
molecul
phosphatidylinositol
studi
found
doubl
nasal
fh
level
associ
time
increas
odd
carriag
time
increas
geometr
mean
carriag
densiti
investig
whether
nasal
wash
fluid
contain
fh
would
influenc
bacteri
adher
fh
bind
pneumococcu
result
greater
vitro
epitheli
adher
effect
partial
reduc
purifi
human
antipspc
antibodi
explor
reason
behind
partial
reduct
map
pspc
epitop
reveal
adult
lack
antipspc
antibodi
recogn
fh
bind
site
result
suggest
block
interact
mucos
vaccin
could
potenti
reduc
colon
densiti
viralassoci
pneumococc
diseas
burden
total
healthi
subject
age
year
challeng
pneumococcu
novemb
april
averag
age
subject
year
male
oropharyng
swab
taken
day
challeng
analyz
pcr
presenc
urt
virus
nasal
wash
sampl
taken
day
inocul
analyz
presenc
pneumococc
carriag
classic
microbiolog
experiment
carriag
pneumococcu
detect
subject
defin
presenc
pneumococci
nasal
wash
time
point
challeng
investig
whether
presenc
viru
predispos
certain
individu
colon
signific
differ
virusposit
virusneg
subject
regard
age
vs
year
gender
mf
vs
inocul
dose
among
virusposit
subject
becam
colon
compar
virusneg
subject
figur
could
find
associ
presenc
viru
increas
densiti
figur
durat
colon
data
shown
infect
caus
singl
viru
detect
detect
virus
among
colon
subject
rhinoviru
coronaviru
respiratori
syncyti
viru
parainfluenza
viru
similarli
noncolon
individu
posit
rhinoviru
coronaviru
adenoviru
investig
level
mucos
fh
secretori
leukocyt
proteinas
inhibitor
slpi
lactoferrin
nasal
wash
determin
whether
modul
innat
factor
viru
could
predispos
individu
pneumococc
colon
level
fh
figur
slightli
higher
nasal
wash
sampl
subject
coinfect
viru
pneumococci
compar
virusonli
individu
contrast
level
antimicrobi
factor
slpi
figur
antimicrobi
figur
lactoferrin
figur
significantli
differ
viral
infect
individu
colon
pneumococci
slightli
high
level
fh
investig
relationship
fh
bacteri
colon
densiti
found
individu
high
mucos
fh
level
increas
colon
densiti
figur
use
gener
estim
equat
gee
model
examin
associ
viru
presenc
mucos
fh
level
individu
well
jointli
carriag
presenc
densiti
tabl
examin
effect
viru
presenc
mucos
fh
level
individu
gee
model
viru
presenc
associ
time
increas
odd
becom
colon
doubl
fh
level
associ
time
increas
geometr
mean
carriag
densiti
examin
effect
jointli
gee
model
found
interact
specif
among
viru
posit
doubl
fh
level
associ
time
increas
odd
carriag
time
increas
geometr
mean
carriag
densiti
use
model
noninflam
inflam
nasopharyng
epithelium
investig
role
mucos
fh
pneumococc
adher
health
coinfect
respect
inflamm
epithelium
confirm
increas
express
polymer
immunoglobulin
receptor
receptor
plateletactiv
factor
data
shown
observ
twofold
increas
pneumococc
adher
inflam
epithelium
compar
noninflam
epithelium
figur
black
squar
test
whether
either
pure
fh
nasal
wash
contain
fh
would
influenc
bacteri
adher
pneumococc
proteas
cleav
antibodi
found
nasal
promot
pneumococc
import
mechan
use
nasal
wash
sampl
deplet
iga
igg
pretreat
bacteria
pure
fh
increas
pneumococc
adher
noninflam
inflam
epithelium
figur
open
dot
adher
depend
pspc
express
figur
pretreat
bacteria
nasal
wash
sampl
deplet
iga
figur
gray
dot
igg
figur
black
dot
equal
increas
pneumococc
adher
nasopharyng
cell
effect
independ
pspc
express
figur
observ
increas
intern
bacteria
pretreat
fh
figur
open
dot
nasal
wash
iga
deplet
figur
gray
dot
nasal
wash
igg
deplet
figur
black
dot
effect
mark
epithelium
inflam
investig
whether
antipspc
antibodi
purifi
individu
particip
ehpc
model
could
block
fh
bind
pneumococcu
vitro
circumv
increas
adher
pneumococcu
inflamm
specif
bind
fh
via
pspc
laboratori
strain
confirm
supplementari
figur
b
onlin
antipspc
antibodi
isol
serum
abund
nasal
wash
flow
cytometr
analysi
indic
sampl
subject
antipspc
igg
bound
effect
pneumococcu
figur
use
unpair
ttest
level
igg
bind
variabl
among
sampl
relat
antipspc
igg
level
measur
enzymelink
immunosorb
assay
elisa
supplementari
figur
purifi
sampl
also
measur
level
fh
remain
antipspc
igg
purif
process
supplementari
figur
purifi
sampl
incub
bacteria
addit
fh
order
block
interact
observ
partial
inhibit
fh
bind
pneumococcu
purifi
human
antipspc
igg
sampl
figur
investig
whether
purifi
antipspc
igg
could
block
pneumococc
adher
intern
host
epitheli
cell
epitheli
adher
reduc
purifi
antipspc
igg
figur
gray
dot
contain
residu
fh
residu
antipspc
purif
process
supplementari
figur
presenc
higher
level
fh
figur
open
dot
interact
specif
pspc
treatment
antipspc
igg
alter
adher
figur
gray
dot
intern
inhibit
antipspc
igg
figur
gray
dot
purifi
total
igg
open
squar
explor
reason
ineffici
block
interact
antipspc
igg
use
peptid
array
defin
epitop
pspc
recogn
human
antibodi
use
serum
healthi
adult
challeng
pneumococcu
probe
peptid
array
contain
entir
sequenc
pspc
group
strain
observ
despit
high
level
antipspc
antibodi
sampl
antibodi
recogn
bind
site
fh
figur
support
partial
inhibit
fh
bind
pneumococcu
observ
vitro
figur
secretori
iga
bind
site
recogn
sampl
figur
bind
specif
human
occur
repeat
peptid
array
use
sera
mice
immun
test
hypothesi
pspc
would
mask
bind
fh
therefor
mice
would
produc
antibodi
region
found
sera
immun
mice
recogn
bind
site
fh
well
peptid
alreadi
identifi
human
sera
supplementari
figur
find
support
previou
result
suggest
import
interact
occur
nasopharynx
pneumococc
colon
pneumonia
evolv
sever
strategi
adher
host
cell
evad
host
complement
immun
attack
shown
viru
coinfect
associ
three
time
increas
odd
becom
colon
presenc
viru
mucos
level
fh
increas
may
partli
explain
predisposit
viral
infect
individu
pneumococc
carriag
ehpc
model
increas
fh
level
also
associ
increas
carriag
densiti
result
corrobor
previou
report
show
carriag
isol
present
greater
bind
fh
system
support
relev
interact
upper
airway
howev
could
observ
correl
viral
coinfect
increas
colon
densiti
contrast
find
recent
publish
wolter
et
found
relationship
increas
pneumococc
colon
densiti
respiratori
viru
coinfect
south
african
treat
acut
lower
respiratori
tract
infect
could
result
differ
recruit
studi
includ
healthi
asymptomat
adult
wherea
south
african
studi
recruit
hospit
individu
age
includ
year
old
hiv
posit
use
gee
model
found
interact
viru
presenc
suscept
colon
increas
colon
densiti
increas
fh
level
first
time
asymptomat
urt
viral
infect
directli
associ
increas
pneumococc
colon
increas
mucos
fh
level
healthi
adult
unabl
detect
fh
express
epitheli
cell
vitro
stimul
nasal
wash
sampl
contain
viru
data
shown
previou
transcriptom
epitheli
cell
found
express
fh
gene
upregul
viru
therefor
like
increas
fh
level
mucosa
sourc
increas
local
express
leakag
blood
stream
nasal
mucosa
inflamm
caus
pneumococcu
viru
investig
effect
nasal
wash
contain
fh
pneumococc
adher
noninflam
inflam
epithelium
observ
treatment
pneumococcu
nasal
wash
contain
sever
innat
factor
includ
fh
promot
increas
epitheli
attach
intern
effect
pronounc
bacteria
treat
purifi
human
fh
epithelium
inflam
use
pneumococc
strain
lack
express
pspc
show
pspc
mediat
effect
fh
epitheli
adher
although
express
strain
use
human
inocul
express
similar
ntermin
first
amino
acid
pspc
amino
acid
sequenc
strain
increas
adher
promot
nasal
wash
caus
exist
fh
alon
sampl
observ
differ
adher
nasal
wash
sampl
deplet
igg
iga
use
treat
therefor
iga
interact
main
mechan
increas
adher
either
sever
pneumococcalspecif
interact
could
play
role
epitheli
interact
pspc
vitronectin
recent
highlight
import
mechan
pneumococc
hypothes
presenc
antipspc
igg
low
level
fh
decreas
pneumococc
adher
antipspc
antibodi
block
adher
mediat
factor
vitronectin
figur
middl
fh
continu
facilit
low
level
adher
human
antipspc
antibodi
recogn
fh
bind
site
fh
level
high
pneumococc
adher
increas
interact
pspc
fh
figur
right
decreas
adher
caus
bind
antipspc
antibodi
factor
vitronectin
mask
increas
bind
adher
observ
interact
associ
high
rate
densiti
carriag
human
coinfect
viru
test
whether
antibodi
vaccin
candid
pspc
could
block
interact
pspcbase
vaccin
protect
invas
pulmonari
diseas
colon
murin
model
observ
partial
block
fh
bind
pneumococcu
flow
cytometri
analysi
epitheli
adher
assay
antipspc
igg
purifi
serum
block
bacteri
attach
low
level
fh
present
assay
result
could
explain
fact
healthi
adult
antibodi
specif
pspc
region
bind
fh
use
sera
mice
immun
pspc
assay
found
human
carriag
induc
antipspc
antibodi
epitop
one
induc
parenter
immun
purifi
protein
mice
two
major
differ
mice
antibodi
prolinerich
region
pspc
although
one
recogn
region
human
antibodi
ii
human
antibodi
recogn
bind
site
fh
pspc
wherea
immun
mice
crossreact
antibodi
prolinerich
region
pspa
could
explain
high
level
recognit
pspc
prolinerich
region
previous
observ
colon
increas
mucos
igg
antibodi
ntermin
region
pspa
importantli
fact
human
ineffici
present
pspc
region
bind
fh
strongli
suggest
fh
bind
pneumococcu
colon
cover
site
pspc
antigen
find
confirm
previou
report
pspc
major
protein
bind
fh
interact
allow
pneumococci
protect
complement
well
facilit
pneumococc
adher
uptak
human
epitheli
increas
adher
lung
epitheli
cell
also
report
pneumococci
preincub
could
explain
associ
high
burden
pneumonia
follow
influenza
polymorph
fh
gene
associ
increas
suscept
staphylococcu
aureu
colon
bind
human
fh
also
describ
import
interact
neisseria
fh
bind
protein
compon
first
licens
vaccin
n
meningitidi
serogroup
point
mutat
elimin
fh
bind
shown
enhanc
protect
antibodi
respons
vaccin
use
meningococc
fh
bind
result
support
use
pspc
mucos
vaccin
candid
highlight
mutat
fh
bind
site
allow
antibodi
gener
region
consid
vaccin
base
pspc
block
interact
specif
pspc
antibodi
mucosa
potenti
reduc
viralassoci
pneumococc
colon
burden
pneumonia
associ
viral
infect
ehpc
studi
pneumococc
detect
healthi
adult
subject
enrol
inform
consent
ehpc
particip
nonsmok
adult
age
year
close
contact
atrisk
individu
includ
young
children
age
year
elderli
year
comorbid
ethic
approv
obtain
nation
health
servic
research
ethic
committe
studi
sponsor
royal
liverpool
broadgreen
univers
hospit
trust
nasal
wash
sampl
obtain
day
intranas
inocul
pneumonia
serotyp
day
inocul
inocul
dose
colonyform
unit
cfu
per
bacteri
prepar
inocul
subject
pneumococcu
nasal
wash
sampl
carriag
detect
quantif
carriag
densiti
done
describ
detect
identif
urt
viru
oropharyng
swab
collect
day
intranas
inocul
immedi
put
viral
transport
medium
mwe
corsham
uk
viral
multiplex
pcr
perform
describ
briefli
viral
rna
extract
viral
transport
medium
elut
buffer
use
standard
pathogen
complex
protocol
qiasymphoni
qiagen
crawley
uk
eluat
analyz
use
four
multiplex
pcr
assay
realtim
pcr
machin
roch
diagnost
burgess
hill
uk
assay
panel
cover
qualit
detect
influenza
b
respiratori
syncyti
viru
human
metapneumoviru
human
rhinoviru
parainfluenza
virus
coronavirus
level
fh
lactoferrin
slpi
nasal
wash
antipspc
sera
sampl
measur
level
fh
plate
coat
nasal
wash
sampl
serial
dilut
buffer
purifi
human
fh
calbiochem
watford
uk
use
standard
goat
antifh
antibodi
calbiochem
follow
antigoat
igg
horseradish
peroxidaseconjug
r
system
abingdon
uk
use
detect
develop
tmb
substrat
reagent
set
bd
oxford
uk
level
lactoferrin
assaypro
st
charl
mo
slpi
r
antigenix
america
huntington
station
ny
measur
sandwich
elisa
follow
manufactur
recommend
briefli
plate
coat
antihuman
lactoferrin
assaypro
slpi
r
plate
block
phosphatebuff
salin
pb
bovin
serum
albumin
nasal
wash
sampl
serial
dilut
bovin
serum
albumin
ad
human
lactoferrin
assaypro
recombin
human
slpi
r
use
standard
biotinyl
rabbit
antilactoferrin
goat
antislpi
follow
streptavidinalkalin
phosphatas
abd
serotec
kidlington
uk
use
detect
develop
mg
pnitrophenyl
phosphat
absorb
nm
measur
assay
use
fluostar
omega
plate
reader
bmg
labtech
aylesburi
uk
level
measur
use
kit
per
manufactur
instruct
antigenix
america
level
antipspc
igg
measur
elisa
use
plate
coat
recombin
purifi
pspc
standard
sera
sampl
known
antipspc
concentr
previous
describ
use
last
dilut
sampl
optic
densiti
calcul
sampl
fourparamet
fit
use
gener
standard
curv
sampl
run
triplic
sampl
coeffici
variat
repeat
deplet
purif
antibodi
nasal
wash
sera
sampl
nasal
wash
sampl
subject
pool
igg
iga
deplet
antihuman
igg
antihuman
iga
agaros
sigmaaldrich
gillingham
uk
respect
sampl
incub
agaros
flowthrough
fraction
use
pneumococc
adher
assay
dot
blot
assay
perform
confirm
antibodi
deplet
data
shown
serum
sampl
seven
subject
use
antipspc
igg
purif
first
purifi
total
igg
obtain
individu
sampl
hitrap
protein
g
affin
column
ge
healthcar
littl
chalfont
uk
purifi
sampl
load
cnbractiv
sepharos
coupl
recombin
purifi
pspc
coupl
mg
ligand
pspc
mg
sepharos
antipspc
purif
perform
per
manufactur
instruct
confirm
antipspc
igg
purif
elisa
perform
use
plate
coat
pspc
previous
bacteri
cultur
vitro
assay
pneumococci
grown
todd
hewitt
broth
supplement
yeast
extract
thi
optic
densiti
reach
bacteria
either
use
immedi
flow
bind
assay
resuspend
thi
glycerol
store
adher
assay
fh
bind
antibodi
bind
assay
bacteri
stock
wash
resuspend
pb
inhibit
fh
bind
cfu
resuspend
individu
nasal
wash
sampl
purifi
iga
igg
sampl
undilut
purifi
antipspc
igg
dilut
incub
min
evalu
satur
concentr
fh
bind
posit
control
inhibit
fh
bind
experi
bacteri
pellet
resuspend
purifi
human
fh
calbiochem
incub
min
sampl
wash
pb
incub
goat
antifactor
h
calbiochem
min
wash
incub
fitcconjug
antigoat
sigmaaldrich
dark
min
sampl
wash
twice
resuspend
pb
paraformaldehyd
store
acquisit
use
bd
lsr
ii
flow
cytomet
total
bacteri
event
acquir
sampl
gate
rel
neg
control
contain
antifh
antipspc
igg
bind
evalu
incub
bacteri
pellet
individu
purifi
human
antipspc
igg
sampl
min
detect
use
antihuman
igg
fitc
antibodi
sigmaaldrich
fh
bind
pneumonia
often
strongli
posit
weakli
neg
popul
bacteria
result
present
fluoresc
index
percentag
posit
bacteria
multipli
geometr
mean
fluoresc
index
arbitrari
unit
pharyng
epitheli
cell
inflamm
epithelium
detroit
pharyng
epitheli
cell
grown
maintain
confluenc
flask
bd
eagl
minim
essenti
media
emem
sigmaaldrich
supplement
fetal
bovin
serum
invitrogen
paisley
uk
mm
lglutamin
sigmaaldrich
u
penicillin
streptomycin
neomycin
sigmaaldrich
complet
media
adher
experi
cell
releas
use
edtatrypsin
invitrogen
wash
media
suspens
cell
seed
per
ml
complet
media
plate
ml
per
well
cell
readi
use
adher
experi
day
seed
confluenc
inflam
epithelium
cell
stimul
tumor
necrosi
factor
ng
complet
emem
h
cell
wash
time
warm
pb
emem
without
antibiot
ad
well
addit
pneumococci
epitheli
polymer
immunoglobulin
receptor
plateletactiv
factor
receptor
express
flow
cytometri
stimul
inflam
nonstimul
noninflam
cell
scrape
well
wash
cold
pb
cell
suspens
incub
plateletactiv
factor
receptor
human
monoclon
antibodi
polymer
immunoglobulin
receptor
rabbit
polyclon
antibodi
cambridg
bioscienc
cambridg
uk
min
antihuman
peconjug
antirabbit
fitcconjug
antibodi
ad
min
cell
wash
store
acquisit
use
bd
lsr
ii
flow
cytomet
total
gate
event
record
pe
goat
antimous
fitc
donkey
antirabbit
igg
biolegend
london
uk
use
isotyp
control
pneumococc
adher
intern
assay
bacteri
pellet
wash
pb
contain
sigmaaldrich
resuspend
dilut
cfu
emem
antibiot
bacteri
suspens
ad
well
contain
cell
per
well
plate
gentli
shaken
obtain
well
dilut
initi
cfu
quantif
blood
agar
plate
oxoid
basingstok
uk
plate
incub
h
well
wash
time
pb
remov
unbound
bacteria
cell
either
lyse
saponin
min
adher
treat
ampicillin
emem
ml
per
well
h
lyse
intern
recov
bacteria
quantifi
serial
dilut
blood
agar
plate
plate
incub
overnight
initi
recov
cfu
count
averag
initi
cfu
valu
use
creat
correct
factor
recov
cfu
strain
could
compar
condit
perform
duplic
experi
perform
least
twice
experi
averag
recov
cfu
control
condit
adher
untreat
bacteria
noninflam
cell
use
calcul
fold
chang
remain
condit
antipspc
antibodi
epitop
map
overlap
peptid
array
contain
peptid
frameshift
four
residu
correspond
amino
acid
sequenc
genbank
access
synthes
slide
support
celluspot
intavi
cologn
germani
peptid
array
incub
individu
sera
sampl
collect
subject
inocul
pneumococcu
mice
immun
dose
contain
alum
previous
concentr
pneumococcalspecif
antibodi
standard
sampl
use
incub
contain
pspc
igg
detect
perform
use
alkalin
phosphataseconjug
antimous
igg
antihuman
igg
sigmaaldrich
mtt
methylthiazolyldiphenyltetrazolium
bromid
bcip
phosphat
citratebuff
salin
ph
use
develop
statist
analysi
fisher
exact
test
use
compar
proport
carrier
viru
posit
viru
neg
pearson
correl
coeffici
use
compar
logtransform
fh
level
pneumococc
carriag
densiti
flow
cytometri
data
analyz
use
flow
jo
tree
star
ashland
account
possibl
correl
among
repeat
measur
carriag
statu
densiti
gee
model
employ
data
analysi
gee
analysi
carriag
presenc
ye
binomi
distribut
logit
link
function
use
gee
analysi
carriag
densiti
logtransform
densiti
use
depend
variabl
normal
distribut
ident
link
function
use
three
gee
model
estim
assess
effect
fh
level
viru
statu
carriag
statu
densiti
separ
jointli
model
viru
statu
posit
neg
day
day
predictor
model
fh
level
log
scale
day
predictor
model
fh
level
viru
statu
day
interact
fh
level
viru
predictor
differ
consid
signific
statist
analys
graphic
present
perform
use
graphpad
la
jolla
ca
cari
nc
